These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31167539)

  • 1. Remnant Lipoprotein Cholesterol Independently Associates With In-Stent Restenosis After Drug-Eluting Stenting for Coronary Artery Disease.
    Xu X; Pandit RU; Han L; Li Y; Guo X
    Angiology; 2019 Oct; 70(9):853-859. PubMed ID: 31167539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study.
    Qin Z; Zhou K; Li YP; Wang JL; Cheng WJ; Hu CP; Shi C; He H; Zhou YJ
    Cardiovasc Diabetol; 2019 Jan; 18(1):11. PubMed ID: 30691501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Levels of Very Low-density Lipoprotein Cholesterol Independently Associated with In-stent Restenosis in Diabetic Patients after Drug-eluting Stent Implantation.
    Qin Z; Zheng FW; Zeng C; Zhou K; Geng Y; Wang JL; Li YP; Ji QW; Zhou YJ
    Chin Med J (Engl); 2017 Oct; 130(19):2326-2332. PubMed ID: 28836572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis.
    Zeng M; Yan X; Wu W
    BMC Cardiovasc Disord; 2021 Sep; 21(1):446. PubMed ID: 34535088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Biomarkers for Coronary Restenosis Occurrence After Drug-Eluting Stent Implantation in Patients With Diabetes Having Stable Coronary Artery Disease.
    Gabbasov Z; Kozlov S; Melnikov I; Byazrova S; Saburova O; Prokofieva L; Caprnda M; Curilla E; Gaspar L; Rodrigo L; Kruzliak P; Smirnov V
    Clin Appl Thromb Hemost; 2018 Nov; 24(8):1308-1314. PubMed ID: 29716394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between fibrinogen-to-albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting.
    Chen T; Sun JL; Zhang J
    Coron Artery Dis; 2020 Nov; 31(7):586-589. PubMed ID: 32271235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prediction model based on platelet parameters, lipid levels, and angiographic characteristics to predict in-stent restenosis in coronary artery disease patients implanted with drug-eluting stents.
    Gai MT; Zhu B; Chen XC; Liu F; Xie X; Gao XM; Ma X; Fu ZY; Ma YT; Chen BD
    Lipids Health Dis; 2021 Sep; 20(1):118. PubMed ID: 34587955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of serum visfatin in predicting in-stent restenosis of drug-eluting stents.
    Wu XA; Xie G; Li XQ; Wu HT; Wang X
    Clin Chim Acta; 2018 Apr; 479():20-24. PubMed ID: 29305846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent predictors of in-stent restenosis after drug-eluting stent implantation for ostial right coronary artery lesions.
    Watanabe Y; Takagi K; Naganuma T; Kawamoto H; Fujino Y; Ishiguro H; Tahara S; Kurita N; Hosawa K; Nakamura S; Nakamura S
    Int J Cardiol; 2017 Aug; 240():108-113. PubMed ID: 28476515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis.
    Zhao L; Zhu W; Zhang X; He D; Guo C
    BMC Cardiovasc Disord; 2017 Jan; 17(1):16. PubMed ID: 28061808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between uric acid to albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting.
    Liu W; Ding K; Bao J; Hu Y; Gui Y; Ye L; Wang L
    Coron Artery Dis; 2023 Dec; 34(8):589-594. PubMed ID: 37855441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up.
    Zhao LP; Xu WT; Wang L; Li H; Shao CL; Gu HB; Chan SP; Xu HF; Yang XJ
    Coron Artery Dis; 2015 Jan; 26(1):5-10. PubMed ID: 25211654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predictors of in-stent restenosis in coronary heart disease patients complicating with diabetes mellitus within 2 years after drug-eluting stents implantation].
    Chen J; Chen Y; Tian F; Han Y; Jing J; Liu J; Wang J; Zhou S
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Jan; 42(1):14-8. PubMed ID: 24680263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictor of in-stent restenosis in patients with drug-eluting stent (PRIDE)- a retrospective cohort study.
    Gupta PK; Balachander J
    Clin Investig Arterioscler; 2021; 33(4):184-194. PubMed ID: 33622608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the Endothelial Nitric Oxide Synthase Gene T786C Polymorphism with In-Stent Restenosis in Chinese Han Patients with Coronary Artery Disease Treated with Drug-Eluting Stent.
    Zeng WP; Zhang R; Li R; Luo JF; Hu XF
    PLoS One; 2017; 12(1):e0170964. PubMed ID: 28129392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New predictors of in-stent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drug-eluting stent.
    Wang JL; Qin Z; Wang ZJ; Shi DM; Liu YY; Zhao YX; Yang LX; Cheng WJ; Zhou YJ
    J Geriatr Cardiol; 2018 Feb; 15(2):137-145. PubMed ID: 29662507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
    Zhao K; Li YJ; Gao S
    Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.
    Takasawa Y; Iijima R; Shiba M; Nakamura M; Sugi K
    J Cardiol; 2010 May; 55(3):391-6. PubMed ID: 20350511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.
    Miki K; Fujii K; Kawasaki D; Shibuya M; Fukunaga M; Imanaka T; Tamaru H; Sumiyoshi A; Nishimura M; Horimatsu T; Saita T; Okada K; Kimura T; Honda Y; Fitzgerald PJ; Masuyama T; Ishihara M
    J Endovasc Ther; 2016 Jun; 23(3):424-32. PubMed ID: 27044270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of red cell distribution width with in-stent restenosis in patients with stable coronary artery disease.
    Kurtul A; Murat SN; Yarlioglues M; Duran M; Karadeniz M; Ergun G; Akyel A; Mendi MA; Oksuz F
    Platelets; 2015; 26(1):48-52. PubMed ID: 24831828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.